Cargando…
Differences in skeletal muscle loss caused by cytotoxic chemotherapy and molecular targeted therapy in patients with advanced non‐small cell lung cancer
BACKGROUND: Recent studies have revealed a reduction in the skeletal muscle area in patients with advanced non‐small cell lung cancer (NSCLC) after chemotherapy. EGFR and ALK tyrosine kinase inhibitor (TKI)‐based therapies are less cytotoxic than chemotherapy, but differences in skeletal muscle mass...
Autores principales: | Kakinuma, Kazutaka, Tsuruoka, Hazime, Morikawa, Kei, Furuya, Naoki, Inoue, Takeo, Miyazawa, Teruomi, Mineshita, Masamichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754304/ https://www.ncbi.nlm.nih.gov/pubmed/29067769 http://dx.doi.org/10.1111/1759-7714.12545 |
Ejemplares similares
-
Severe tracheal stenosis with tracheopathia osteoplastica-like changes due to traumatic blunt injury
por: Kakinuma, Kazutaka, et al.
Publicado: (2014) -
Suitability of transbronchial brushing cytology specimens for next‐generation sequencing in peripheral lung cancer
por: Furuya, Naoki, et al.
Publicado: (2020) -
A prospective observational study to assess PD-L1 expression in small biopsy samples for non-small-cell lung cancer
por: Tsunoda, Akihito, et al.
Publicado: (2019) -
Drastic healing process after pembrolizumab monotherapy in a case of advanced squamous cell carcinoma with severe bronchial stenosis observed over a two‐year period using continuous bronchoscopy: A case report
por: Morikawa, Kei, et al.
Publicado: (2020) -
RET fusion mutation detected by re-biopsy 7 years after initial cytotoxic chemotherapy: A case report
por: Morikawa, Kei, et al.
Publicado: (2022)